Titular de la autorización de comercialización · Estados Unidos
Abraxis Pharm
23 medicamentos en 1 país, como titular de la autorización.
Estructura del grupo
Parte de
AbraxisGrupo farmacéuticoOtras empresas del grupo
Estados Unidos1
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Medicamentos
Todos los medicamentos registrados a su nombre, primero los vigentes.
23 medicamentos
| Medicamento | Principio activo | País | Estado | Autorización |
|---|---|---|---|---|
| BRETYLIUM TOSYLATE100MG/ML | 50MG/ML | 50MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Bretylium tosilate | Estados Unidos | No comercializado | 1986 |
| CALCIUM GLUCEPTATE90mg calcium/5ml · Injectable | Gluceptate | Estados Unidos | No comercializado | 1970 |
| CEPHAPIRIN SODIUM1gm base/vial | 20gm base/vial | 2gm base/vial | 4gm base/vial | 500mg base/vial · Injectable | Cephapirin | Estados Unidos | No comercializado | 1987 |
| CHLORPROMAZINE HYDROCHLORIDE25mg/ml · Injectable | Chlorpromazine | Estados Unidos | Comercializado | 1974 |
| CHROMIC CHLORIDE0.004mg chromium/ml · Injectable | Chromic | Estados Unidos | Comercializado | 1987 |
| CUPRIC SULFATE0.4MG COPPER/ML | 0.4MG COPPER/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Cupric | Estados Unidos | Comercializado | 1987 |
| DEXAMETHASONE10mg phosphate/ml | 4mg phosphate/ml · Injectable | Dexamethasone | Estados Unidos | No comercializado | 1984 |
| DIAZOXIDE15mg/ml · Injectable | Diazoxide | Estados Unidos | No comercializado | |
| FLUOROURACIL1GM/20ML (50MG/ML) | 2.5GM/50ML (50MG/ML) | 2.5GM/50ML (50MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 500MG/10ML (50MG/ML) | 500MG/10ML (50MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 50MG/ML | 5GM/100ML (50MG/ML) · Injectable | Fluorouracil | Estados Unidos | Comercializado | 1962 |
| HYDROCORTISONE SODIUM SUCCINATE100mg base/vial | 1gm base/vial | 250mg base/vial | 500mg base/vial · Injectable | Hydrocortisone | Estados Unidos | Comercializado | 1981 |
| LEUCOVORIN CALCIUM100MG BASE/VIAL | 100MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 200MG BASE/VIAL | 350MG BASE/VIAL | 350MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 500MG BASE/VIAL | 50MG BASE/VIAL | 50MG BASE/VIAL **Federal Register deter · Injectable | Calcium folinate | Estados Unidos | Comercializado | 1952 |
| LIDOCAINE HYDROCHLORIDE0.5% | 1.5% | 1% | 10% | 1gm/vial | 2% | 20% | 2gm/vial | 4% · Injectable | Lidocaine | Estados Unidos | Comercializado | 1972 |
| M.V.C. 9+310mg/ml; 0.006mg/ml; 0.5mcg/ml; 1.5mg/ml; 20 iu/ml; 0.04mg/ml; 4mg/ml; 0.4mg/ml; 5'-phosphate sodium 0.36mg/ml; 0.3mg/ml; 330 units/ml; 1 iu/ml · Injectable | Ascorbic acid, Biotin, Vitamin b12, Dexpanthenol, Ergocalciferol, Folic acid, Niacinamide, Vitamin b6, Vitamin b2, Vitamin b1, Vitamin a, Vitamin e | Estados Unidos | No comercializado | 1981 |
| MANGANESE SULFATE0.1MG MANGANESE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Manganese | Estados Unidos | No comercializado | 1987 |
| METARAMINOL BITARTRATE10mg base/ml | 20mg base/ml · Injectable | Metaraminol | Estados Unidos | Comercializado | 1972 |
| METHYLPREDNISOLONE SODIUM SUCCINATE125mg base/vial | 1gm base/vial | 2gm base/vial | 40mg base/vial | 500mg base/vial · Injectable | Methylprednisolone | Estados Unidos | Comercializado | 1980 |
| METRONIDAZOLE HYDROCHLORIDE500mg base/vial · Injectable | Metronidazole | Estados Unidos | No comercializado | |
| NALBUPHINE10mg/ml (10mg/ml) | 200mg/10ml (20mg/ml) | 20mg/ml (20mg/ml) · Solution | Nalbufine | Estados Unidos | No comercializado | 1986 |
| POTASSIUM CHLORIDE1.5meq/ml | 1meq/ml | 2.4meq/ml | 2meq/ml | 3.2meq/ml | 3meq/ml | 4meq/ml · Injectable | Potassium chloride | Estados Unidos | Comercializado | 1971 |
| RITODRINE HYDROCHLORIDE10mg/ml | 15mg/ml · Injectable | Ritodrine | Estados Unidos | No comercializado | 1987 |
| SODIUM CHLORIDE 23.4% IN PLASTIC CONTAINER234MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Sodium chloride | Estados Unidos | No comercializado | |
| SULFAMETHOXAZOLE AND TRIMETHOPRIM80mg/ml; 16mg/ml · Injectable | Sulfamethoxazole, Trimethoprim | Estados Unidos | Comercializado | 1987 |
| ZINC SULFATE1mg zinc/ml · Injectable | Zinc | Estados Unidos | No comercializado | 1987 |